Treatment of anemia with Aranesp™ (darbepoetin alfa) improves health related quality of life (HRQOL) in patients with chronic kidney disease (CKD).

被引：0

作者：

Thadhani, R

Cheriyan, R

Brenner, R

Ford, J

Powers, K

Rahman, SN

机构：

[1] Univ Texas, Hlth Sci Ctr, Houston, TX USA

[2] Amgen Inc, Thousand Oaks, CA 91320 USA

[3] Virginia Nephrol Grp, Fairfax, VA USA

[4] Massachusetts Gen Hosp, Boston, MA 02114 USA

来源：

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2002年 / 13卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：637A / 637A

页数：1

共 50 条

[31] Darbepoetin alfa - Its use in anemia associated with chronic kidney disease
Robinson, DM
Easthope, SE
BIODRUGS, 2005, 19 (05) : 327 - 343
[32] Darbepoetin alfa, a new therapy for the management of anemia of chronic kidney disease
Hudson, JQ
Sameri, RM
PHARMACOTHERAPY, 2002, 22 (09): : 141S - 149S
[33] Drug safety profile of darbepoetin alfa for anemia of chronic kidney disease
Agarwal, Anil K.
EXPERT OPINION ON DRUG SAFETY, 2009, 8 (02) : 145 - 153
[34] Maintenance treatment with natalizumab improves the health related quality of life (HRQOL) in Crohn's disease patients
Feagan, Brian
Colombel, Jean-Frederic
Enns, Robert
Hanauer, Stephen
Lawrance, Ian
Panaccione, Remo
Rutgeerts, Paul
Schreiber, Stefan
Targan, Stephan
Deventer, Sander van
Sandborn, William
GASTROENTEROLOGY, 2006, 130 (04) : A485 - A485
[35] Evaluation of efficacy of darbepoetin alfa administered once monthly as treatment of anemia in predialysis patients with chronic kidney disease
Martínez, PM
de Vinuesa, SG
Díaz, MO
Goicoechea, M
Campderá, FG
Luño, J
NEFROLOGIA, 2005, 25 (06): : 663 - 667
[36] Anemia treatment patterns in chronic kidney disease in pre-dialysis patients using darbepoetin alfa (NESP)
Lunde, Martin
Fahrbach, Kyle
Nalysnyk, Luba
del Aguila, Michael
AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (04) : A57 - A57
[37] The Impact of Anemia Treatment on Health-Related Quality of Life in Patients With Chronic Kidney Disease in the Contemporary Era
Finkelstein, Fredric O.
Finkelstein, Susan H.
ADVANCES IN CHRONIC KIDNEY DISEASE, 2019, 26 (04) : 250 - 252
[38] Aranesp® (darbepoetin alfa) administered every other week (Q2W) corrects and maintains hemoglobin (Hb) in chronic kidney disease (CKD) patients
Hertel, J
Locay, H
Scarlata, D
Prathikanti, R
Audhya, P
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (04) : A31 - A31
[39] Natalizumab improves the health related quality of life (HRQOL) in Crohn's disease patients
Feagan, B
Enns, R
Colombel, JF
Hanauer, S
Lawrance, I
Panaccione, R
Rutgeerts, P
Sanders, M
Schreiber, S
Targan, S
van Deventer, S
Sandborn, W
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S310 - S311
[40] DARBEPOETIN ALFA ONCE IN 4 WEEKS CORRECTS ANEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE NOT ON DIALYSIS
Park, Mooyong
Choi, Soo Jeong
Kim, Jin Kuk
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I1183 - I1184

← 1 2 3 4 5 →